FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

L-Cysteine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 01/09/2015
»Therapeutic Categories: Other; Pediatric

Expand all

Sandoz (Reverified 04/27/2017)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg/mL 10x10 mL vial (NDC 66758-004-02) Product permanently discontinued Discontinuation of the manufacture of the drug
50 mg/mL 5x50 mL vial (NDC 66758-005-02) Product permanently discontinued Discontinuation of the manufacture of the drug
50mg/ml 10x10 ml Vial (NDC 0781-8940-95) Intermittent backorders possible. Full recovery expected in June 2017. Sandoz in conjunction with FDA has initiated temporary importation of L-Cysteine Hydrochloride Injection into the U.S. market to address drug shortage. Importation began July 2016. Please check wholesaler inventory. Please see the Dear Healthcare Professional Letter for additional product and supply information.

Dear Healthcare Professional Letter

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English